Skip to main content
ResMed8-K: Divestiture

ResMed divests MatrixCare business to fund $450M accelerated share repurchase.

What happened

The sale of the MatrixCare business indicates a strategic refocus on core operations and provides significant capital.

Source

SEC EDGARSep 1, 2026

Current report (Form 8-K)

ResMed 8-K

Filing excerpt

The Company intends to fund the accelerated share repurchase with the proceeds from the sale of its MatrixCare business and cash on hand.

sec.gov/Archives/edgar/data/943819/000119312526378487/d530283d8k.htmRead the full source

Other signals in this filing (2)

Extracted by Autobound

From the Signal API record
Signal
8-K: Divestiture

What this signalsFilings often name leadership changes, deals and spending plans.

Form
8-K
Filed
Sep 1, 2026

The full record

From the Signal API record

Numbers

Dollar figure
$450M (Amount of accelerated share repurchase funded by the sale of the MatrixCare business.)

Details

CIK
943819
Accession number
0001193125-26-378487
Timeframe
Current quarter
Filing year
2026
Why it matters
Carve-out support needed
Signal category
Strategic

Topics and mentions

Vendors

  • Citibank

Extraction

Confidence
High
Relevance
90%
Sentiment
Neutral
Detected
Sep 8, 2026
signal_type
sec-8k
signal_subtype
divestiture

Use this data

Get every 8-K signal for ResMed and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at ResMed this week?”

  2. Send it to your own tools

    The Signal API returns 8-K signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-8k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/d2c04415-4a1a-494b-8fed-bee1ebd4d75f returns this record as JSON. POST /v1/companies/enrich returns every signal for resmed.com.

{
  "signal_id": "d2c04415-4a1a-494b-8fed-bee1ebd4d75f",
  "signal_type": "sec-8k",
  "signal_subtype": "divestiture",
  "detected_at": "2026-09-08T07:05:25.959+00:00",
  "company": {
    "name": "ResMed",
    "domain": "resmed.com"
  },
  "data": {
    "detail": "The sale of the MatrixCare business indicates a strategic refocus on core operations and provides significant capital. This corporate restructuring often triggers reviews of existing vendor contracts, IT systems, and operational processes as the company streamlines.",
    "metrics": {
      "timeframe": "current_quarter",
      "dollar_context": "Amount of accelerated share repurchase funded by the sale of the MatrixCare business.",
      "dollar_millions": 450
    },
    "summary": "ResMed divests MatrixCare business to fund $450M accelerated share repurchase.",
    "excerpts": "The Company intends to fund the accelerated share repurchase with the proceeds from the sale of its MatrixCare business and cash on hand.",
    "relevance": 0.9,
    "sentiment": "neutral",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/943819/000119312526378487/d530283d8k.htm",
    "filing_date": "2026-09-01",
    "filing_year": 2026,
    "sales_relevance": "Carve-out support needed",
    "signal_category": "strategic",
    "vendors_mentioned": [
      "Citibank"
    ]
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.